| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 698980 | Null | 0.0176693828663438 | -0.056037783 |
| NSC 723397 | Null | 0.0176693828663438 | 0.26755656 |
| NSC 726195 | 2-phenyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one | 0.0176693828663438 | 0.25451532 |
| NSC 744622 | 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide | 0.0176693828663438 | 0.19854318 |
| NSC 750717 | 5-(2-hydroxyethyl)-9-(3-methoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-8(5H)-one | 0.0176693828663438 | 0.29450522 |
| NSC 764043 | (+)-JQ1 | 0.0176693828663438 | 0.12445897 |
| NSC 269599 | Stannane, chlorohydroxydiphenyl- | 0.0181211508101517 | 0.29330427 |
| NSC 363812 | Tetraplatin | 0.0181211508101517 | 0.46719443 |
| NSC 36437 | 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) | 0.0181211508101517 | 0.40409095 |
| NSC 39135 | Null | 0.0181211508101517 | 0.49706326 |